Literature DB >> 15228727

Declining HIV rates in Uganda: due to cleaner needles, not abstinence or condoms.

Stuart Brody1.   

Abstract

Public health and political authorities have ascribed the apparent decline in Ugandan HIV or AIDS rates to increased rates of sexual abstinence or condom use. However, what appears to be special about Uganda is that in the middle to late 1980s there was a growing public awareness of health care risks. Given the lack of evidence for transmission of HIV to healthy persons by penile-vaginal intercourse, the improvement in injection safety is the best candidate for declining HIV and AIDS rates.

Entities:  

Mesh:

Year:  2004        PMID: 15228727     DOI: 10.1258/0956462041211324

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

1.  Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.

Authors:  William M Gwinn; Shaun M Kirwan; Sheena H Wang; Kathleen A Ashcraft; Neil L Sparks; Catherine R Doil; Tom G Tlusty; Leslie S Casey; Susan K Hollingshead; David E Briles; Richard S Dondero; Anthony J Hickey; W Michael Foster; Herman F Staats
Journal:  Vaccine       Date:  2010-08-17       Impact factor: 3.641

Review 2.  Revisiting the ABC strategy: HIV prevention in Uganda in the era of antiretroviral therapy.

Authors:  S Okware; J Kinsman; S Onyango; A Opio; P Kaggwa
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

3.  Condom and sexual abstinence talk in the Malawi National Assembly.

Authors:  Adamson S Muula
Journal:  Afr Health Sci       Date:  2006-03       Impact factor: 0.927

4.  Wealth and sexual behaviour among men in Cameroon.

Authors:  Eugene J Kongnyuy; Charles S Wiysonge; Robinson E Mbu; Philip Nana; Luc Kouam
Journal:  BMC Int Health Hum Rights       Date:  2006-09-11

5.  HIV epidemiology in Africa: weak variables and tendentiousness generate wobbly conclusions.

Authors:  Stuart Brody; John J Potterat
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

6.  Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.

Authors:  Reinaldo Acevedo; Adriana Callicó; Yisabel Aranguren; Caridad Zayas; Yolanda Valdés; Oliver Pérez; Luis García; Valerie A Ferro; José Luis Pérez
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.